All protein degrader discovery articles
-
Business
Pfizer backs protein degrader drugs with Arvinas deal
$1bn investment to commercialise breast cancer treatment
-
Webinar
Developing small-molecule degraders using chemoproteomics
Discover how chemoproteomics can inform the development of small molecule degraders